Munich, 20 February 2017 -- microDimensions launches a new version of its high precision whole slide alignment software Slidematch. With the new version users can align digital whole slide images from consecutive sections in brightfield and...

  In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive...

The American Society of Clinical Oncology (ASCO), the College of American Pathologists (CAP) and the American Society for Clinical Pathology (ASCP) have issued a joint guideline on HER2 testing for patients with gastroesophageal cancers. Read...

New applications on the platform enable acceleration of breakthroughs in the fight against cancer. Baltimore, MD; San Diego, CA (PRWEB) October 24, 2016 -- Proscia Inc, the industry's leading provider of cloud solutions for digital...

OptraSCANTM On-Demand Digital Pathology announced today the availability of a Breast Cancer Focused Panel of Algorithmic Biomarkers (ER/PR, HER-2/neu, Ki67, P53, EGFR, AE1/AE3) through its OptraASSAYSTM and OptraCARDSTM Solutions, as part of...

More news from Philips this week - announcing a licensing agreement with Visiopharm to combine Visiopharm's breast cancer panel with Philips' Intellisite digital pathology solution. From a scientific standpoint, as the references mentioned...